Safety and clinical outcomes of Phase 1 study of VCN-01 (zabilugene almadenorepvec) in refractory retinoblastoma patients to ...

PHILADELPHIA, PENNSYLVANIA / ACCESS Newswire / January 23, 2026 / Medicus Pharma Ltd. (NASDAQ:MDCX) ("Medicus" or the ...

Seamless Therapeutics entered into a strategic global research collaboration and licensing agreement with Eli Lilly and ...

A Bengaluru oncologist developed Dhwani, a low-cost, patented tracheostomy tube, after a preventable death in rural India.

Revita-treated patients experienced sustained weight maintenance, improved cardiometabolic profile, and reduced food cravings ...

How much should psychedelics researchers disclose about their personal use of psilocybin, ketamine, and other drugs?

Safety and clinical outcomes of Phase 1 study of VCN-01 (zabilugene almadenorepvec) in refractory retinoblastoma patients to be presented in an invited session at the 41st Asia-Pacific Academy of Opht ...

Discusses FDA Complete Response Letter and Next Steps for Anaphylm Epinephrine Sublingual Film February 2, 2026 8:00 ...

Topps WWE crossovers in 2025 reshaped the hobby. Special editions like BAPE (streetwear camo frames with Baby Milo art) and ...

From patient portals and text messages to wearable devices and artificial intelligence, digital health technologies are becoming a significant part of medical care. But technology alone isn't enough ...

AI innovation impact broadens patient access by improving experience and outcomes through patient-reported outcomes in underserved health settings.

Hundreds of millions of people are turning to chatbots to help figure out what's wrong with them. Doctors say that's not ...